SAN DIEGO, Feb. 13, 2014 /PRNewswire/ -- Accelrys, Inc.
(NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software and solutions, today introduced the
Accelrys Science Council, furthering the company's commitment to
advancing the highest levels of scientific research and innovation
across all major scientific industries. The Accelrys Science
Council is comprised of the company's most elite thought leaders
who will guide the direction and sustain the high standard of
company-wide scientific innovation efforts. Leading the
program as Senior Fellows with 53 collective years of experience
are Hugues-Olivier Bertrand, Ph.D.,
Victor Milman, Ph.D. and
Justin Neway, Ph.D.
(Logo:
http://photos.prnewswire.com/prnh/20120416/MM88629LOGO)
"The Accelrys Science Council expands the role of Accelrys' top
scientists in developing and deploying technology solutions that
accelerate products from research to manufacturing," said Accelrys
President and CEO Max Carnecchia.
"Accelrys' deep scientific heritage and expertise is essential to
driving scientific product lifecycle management. With their passion
for science, the Accelrys Fellows will play a critical role in
transforming the next generation of informatics technology required
by our customers."
Senior Fellows will appoint additional Fellows from among
Accelrys' approximately 225 Ph.D. scientists to serve on the
Accelrys Science Council. Accelrys Fellows drive the
development and validation of software solutions for the process
industries that are critical to scientific innovation. Their
insights will serve to influence the development of Accelrys'
industry leading portfolio of scientific innovation lifecycle
management solutions across the entire new product development
cycle.
"Fellows are selected based on their highly regarded published
work, presentations, patent achievements, industry thought
leadership and significant contributions to Accelrys' scientific
advancements," said Bertrand, Ph.D., senior fellow and senior
director at Accelrys. "Those appointed have an in-depth knowledge
of customer environments, processes and business issues; allowing
Accelrys to develop, deliver and support the solutions our
customers need."
Hugues-Olivier Bertrand joined
Accelrys in 1998 as an application scientist. Currently, as a
senior director and senior fellow, Bertrand manages the Life
Science Research Pre-Sales group and his main areas of expertise
include protein modeling, simulations of macrolecules, virtual
screening and structure based drug design. He received his
doctorate in pharmaceutical sciences from University of Rennes,
France. He followed his academic
curriculum with a postdoctoral experience focusing his research
work on computational structural biology at the Institut de
Biologie Physicochimique and Institut Gustave Roussy in
Paris. After joining Accelrys,
Bertrand started developing structural biology and drug discovery
projects on Family 3 GPCRs activated by amino acids. This work,
carried out in collaboration with other experts, gave rise to
several publications, patents, international seminars and doctoral
thesis. Bertrand teaches computational chemistry, comparative
modeling and virtual screening at Institut Gustave Roussy and has
co-supervised several doctoral theses. He is the author of 50
publications in peer-reviewed journals.
Victor Milman joined Accelrys in
1994 and currently serves as a senior fellow and manager of quantum
mechanics and nanotechnology research and development team. He
graduated from Moscow Institute of Physics and Technology and
received his doctorate in solid state physics from The Ukrainian
Academy of Sciences. His subsequent research at the Institute of
Metal Physics in Kiev focused on
development of first principles techniques for study of lattice
properties of inorganic crystals. This work continued at the
Cavendish Laboratory, Cambridge, where
he was employed as a Research Associate for the SERC Collaborative
Computational Project in electronic structure of solids. This
activity in the group of Professor Heine and Professor Payne
culminated in the public release of CASTEP, a revolutionary code
for quantum-mechanical modelling of solids and surfaces. Milman
further worked for a year as a visiting research fellow at the DOE
Oak Ridge National Laboratory, concentrating on applications of
CASTEP to physics of semiconductors, from modelling growth
processes to study of extended defects. Victor Milman has 150 peer-reviewed publications
with the h-index of 29, which reflects both productivity and high
scientific impact of his research. His contributions include
numerous conference presentations, co-supervision of doctorate
students with University of Cambridge
and with University College London, organization of meetings and
symposia, regular refereeing of papers for the major journals in
physics and chemistry.
Justin Neway, general manager,
operations intelligence and senior fellow, joined Accelrys through
the 2012 acquisition of Aegis Analytical Corp, which he founded in
1997 and where he also served as vice president and chief science
officer. He received his doctorate in biochemistry from
University of Illinois studying the
regulation of antibiotic biosynthesis using biochemical, enzymology
and immunology techniques. Neway brings to Accelrys over 30 years
of experience in biotechnology and pharmaceutical process
development and manufacturing, and in the application of software
solutions to operational issues and quality compliance in
biotechnology and pharmaceutical manufacturing. Prior to founding
Aegis, he was with Wyeth Biosciences, Novartis Pharmaceuticals and
Baxter Hemoglobin Therapeutics, where he held positions of
increasing responsibility. Neway's additional contributions
to the field include managing the first CMC regulatory filing for
IL-2, editing a reference book on Process Development of Industrial
Organisms, publishing several refereed journal articles, being an
inventor on several issued patents, chairing and delivering
numerous conference presentations, and publishing numerous thought
leadership articles.
Throughout the year, the Accelrys Science Council will share
research, develop mentorship and guidance and highlight key
advancements in Accelrys science solutions.
Link to Accelrys' Published Research:
http://accelrys.com/innovation/published-research/
Accelrys Website
Follow Accelrys on Twitter
Friend Accelrys on Facebook
Accelrys' YouTube Channel
Connect with Accelrys on LinkedIn
About Accelrys, Inc.
Accelrys (NASDAQ: ACCL), a
leading provider of scientific innovation lifecycle management
software, supports industries and organizations that rely on
scientific innovation to differentiate themselves. The
industry-leading Accelrys Enterprise Platform provides a broad,
flexible scientific foundation optimized to integrate the diversity
of science, experimental processes and information requirements
across the research, development, QA/QC and manufacturing phases of
product development. Accelrys offers capabilities in scientific
data management, modeling and simulation, research informatics,
laboratory informatics, enterprise quality management,
environmental health & safety and operations intelligence for
customers in science-driven industries. Using Accelrys technology,
scientific innovators can access, organize, analyse and share data
in unprecedented ways across the research, laboratory and
manufacturing continuum, ultimately enhancing innovation, improving
productivity and compliance, reducing costs and accelerating
product development from research to manufacturing.
Accelrys solutions are used by more than 2,000 customers in the
pharmaceutical, biotechnology, energy, chemicals, aerospace,
consumer packaged goods and industrial products industries.
Headquartered in San Diego, CA,
Accelrys employs approximately 225 full-time PhD scientists. For
more information about Accelrys, visit www.accelrys.com.
SOURCE Accelrys, Inc.